Modeling of Solid-Tumor Microenvironment in Zebrafish (Danio Rerio) Larvae
- PMID: 32130712
- DOI: 10.1007/978-3-030-34025-4_22
Modeling of Solid-Tumor Microenvironment in Zebrafish (Danio Rerio) Larvae
Abstract
The zebrafish larvae have emerged as a powerful model for studying tumorigenesis in vivo, with remarkable conservation with mammals in genetics, molecular and cell biology. Zebrafish tumor models bear the significant advantages of optical clarity in comparison to that in the mammalian models, allowing noninvasive investigation of the tumor cell and its microenvironment at single-cell resolution. Here we review recent progressions in the field of zebrafish models of solid tumor diseases in two main categories: the genetically engineered tumor models in which all cells in the tumor microenvironment are zebrafish cells, and xenograft tumor models in which the tumor microenvironment is composed of zebrafish cells and cells from other species. Notably, the zebrafish patient-derived xenograft (zPDX) models can be used for personalized drug assessment on primary tumor biopsies, including the pancreatic cancer. For the future studies, a series of high throughput drug screenings on the library of transgenic zebrafish models of solid tumor are expected to provide systematic database of oncogenic mutation, cell-of-origin, and leading compounds; and the humanization of zebrafish in genetics and cellular composition will make it more practical hosts for zPDX modeling. Together, zebrafish tumor model systems are unique and convenient in vivo platforms, with great potential to serve as valuable tools for cancer researches.
Keywords: Animal model; Chimeric antigen receptor (CAR) T-cells; Transgenesis; Tumor microenvironment; Xenograft; Zebrafish.
Similar articles
-
Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment.J Vis Exp. 2019 Apr 30;(146). doi: 10.3791/59507. J Vis Exp. 2019. PMID: 31107449
-
Speeding up Glioblastoma Cancer Research: Highlighting the Zebrafish Xenograft Model.Int J Mol Sci. 2024 May 15;25(10):5394. doi: 10.3390/ijms25105394. Int J Mol Sci. 2024. PMID: 38791432 Free PMC article. Review.
-
Zebrafish Models of Cancer-New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate.Genes (Basel). 2019 Nov 15;10(11):935. doi: 10.3390/genes10110935. Genes (Basel). 2019. PMID: 31731811 Free PMC article. Review.
-
Zebrafish Xenograft Model to Study Human Cancer.Methods Mol Biol. 2022;2413:45-53. doi: 10.1007/978-1-0716-1896-7_6. Methods Mol Biol. 2022. PMID: 35044653
-
Zebrafish In Vivo Models of Cancer and Metastasis.Cold Spring Harb Perspect Med. 2020 Aug 3;10(8):a037077. doi: 10.1101/cshperspect.a037077. Cold Spring Harb Perspect Med. 2020. PMID: 31615862 Free PMC article. Review.
Cited by
-
Patient-Derived Xenotransplant of CNS Neoplasms in Zebrafish: A Systematic Review.Cells. 2022 Apr 2;11(7):1204. doi: 10.3390/cells11071204. Cells. 2022. PMID: 35406768 Free PMC article.
-
Interleukin-15 and chemokine ligand 19 enhance cytotoxic effects of chimeric antigen receptor T cells using zebrafish xenograft model of gastric cancer.Front Immunol. 2022 Dec 23;13:1002361. doi: 10.3389/fimmu.2022.1002361. eCollection 2022. Front Immunol. 2022. PMID: 36618357 Free PMC article.
-
Assessment of stromal SCD-induced drug resistance of PDAC using 3D-printed zPDX model chips.iScience. 2022 Dec 5;26(1):105723. doi: 10.1016/j.isci.2022.105723. eCollection 2023 Jan 20. iScience. 2022. PMID: 36590169 Free PMC article.
-
Zebrafish Models of Cancer Therapy-Induced Cardiovascular Toxicity.J Cardiovasc Dev Dis. 2021 Jan 22;8(2):8. doi: 10.3390/jcdd8020008. J Cardiovasc Dev Dis. 2021. PMID: 33499052 Free PMC article. Review.
-
One Host-Multiple Applications: Zebrafish (Danio rerio) as Promising Model for Studying Human Cancers and Pathogenic Diseases.Int J Mol Sci. 2022 Sep 6;23(18):10255. doi: 10.3390/ijms231810255. Int J Mol Sci. 2022. PMID: 36142160 Free PMC article. Review.
References
-
- Allen-Rhoades W, Whittle SB, Rainusso N (2018) Pediatric solid tumors of infancy: an overview. Pediatr Rev 39(2):57–67. https://doi.org/10.1542/pir.2017-0057 - DOI - PubMed
-
- Avci ME, Keskus AG, Targen S, Isilak ME, Ozturk M, Atalay RC, Adams MM, Konu O (2018) Development of a novel zebrafish xenograft model in ache mutants using liver cancer cell lines. Sci Rep 8(1):1570. https://doi.org/10.1038/s41598-018-19817-w - DOI - PubMed - PMC
-
- Balar AV, Weber JS (2017) PD-1 and PD-L1 antibodies in cancer: current status and future directions. Cancer Immunol Immunother 66(5):551–564. https://doi.org/10.1007/s00262-017-1954-6 - DOI - PubMed
-
- Ban J, Aryee DN, Fourtouna A, van der Ent W, Kauer M, Niedan S, Machado I, Rodriguez-Galindo C, Tirado OM, Schwentner R, Picci P, Flanagan AM, Berg V, Strauss SJ, Scotlandi K, Lawlor ER, Snaar-Jagalska E, Llombart-Bosch A, Kovar H (2014) Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma. Cancer Res 74(22):6578–6588. https://doi.org/10.1158/0008-5472.CAN-14-1736 - DOI - PubMed
-
- Barriuso J, Nagaraju R, Hurlstone A (2015) Zebrafish: a new companion for translational research in oncology. Clin Cancer Res 21(5):969–975. https://doi.org/10.1158/1078-0432.CCR-14-2921 - DOI - PubMed - PMC
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical